| 000 | 01737 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250513094606.0 | ||
| 264 | 0 | _c19970115 | |
| 008 | 199701s 0 0 eng d | ||
| 022 | _a0300-0605 | ||
| 024 | 7 |
_a10.1177/030006059502300601 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSclar, D A | |
| 245 | 0 | 0 |
_aAntidepressant pharmacotherapy: economic evaluation of fluoxetine, paroxetine and sertraline in a health maintenance organization. _h[electronic resource] |
| 260 |
_bThe Journal of international medical research _c |
||
| 300 |
_a395-412 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_a1-Naphthylamine _xanalogs & derivatives |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAntidepressive Agents _xeconomics |
| 650 | 0 | 4 | _aComputer Simulation |
| 650 | 0 | 4 | _aCosts and Cost Analysis |
| 650 | 0 | 4 |
_aDepression _xclassification |
| 650 | 0 | 4 |
_aDepressive Disorder _xclassification |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aFluoxetine _xeconomics |
| 650 | 0 | 4 |
_aHealth Maintenance Organizations _xeconomics |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aMultivariate Analysis |
| 650 | 0 | 4 |
_aParoxetine _xeconomics |
| 650 | 0 | 4 | _aRetrospective Studies |
| 650 | 0 | 4 | _aSertraline |
| 650 | 0 | 4 | _aUnited States |
| 700 | 1 | _aRobison, L M | |
| 700 | 1 | _aSkaer, T L | |
| 700 | 1 | _aGalin, R S | |
| 700 | 1 | _aLegg, R F | |
| 700 | 1 | _aNemec, N L | |
| 700 | 1 | _aHughes, T E | |
| 700 | 1 | _aBuesching, D P | |
| 700 | 1 | _aMorgan, M | |
| 773 | 0 |
_tThe Journal of international medical research _gvol. 23 _gno. 6 _gp. 395-412 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1177/030006059502300601 _zAvailable from publisher's website |
| 999 |
_c8743621 _d8743621 |
||